Peer Review reports
From: Comprehensive pan-cancer analysis on CBX3 as a prognostic and immunological biomarker
| Original Submission | ||
|---|---|---|
| 21 Jul 2021 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| 22 Oct 2021 | Reviewed | Reviewer Report |
| 1 Nov 2021 | Reviewed | Reviewer Report |
| 28 Nov 2021 | Author responded | Author comments - Boyu Sun |
| Resubmission - Version 3 | ||
| 28 Nov 2021 | Submitted | Manuscript version 3 |
| 10 Dec 2021 | Author responded | Author comments - Boyu Sun |
| Resubmission - Version 4 | ||
| 10 Dec 2021 | Submitted | Manuscript version 4 |
| 19 Dec 2021 | Author responded | Author comments - Boyu Sun |
| Resubmission - Version 5 | ||
| 19 Dec 2021 | Submitted | Manuscript version 5 |
| 19 Jan 2022 | Reviewed | Reviewer Report |
| Resubmission - Version 6 | ||
| Submitted | Manuscript version 6 | |
| Publishing | ||
| 31 Jan 2022 | Editorially accepted | |
| 16 Feb 2022 | Article published | 10.1186/s12920-022-01179-y |
You can find further information about peer review here.